About
Tom Heyman is an executive with over 37 years of pharmaceutical experience at Johnson & Johnson across Belgium and the United States. He serves as a board member of Akero Therapeutics, a publicly traded biotech company focused on NASH therapeutics, and holds the position of Executive Partner at Bioqube Ventures, a Belgian venture capital fund.
Experience
- Bioqube VenturesExecutive Partnercurrent2025 — present
- Bioqube VenturesOperating Partner2020 — 2025
- Primmune TherapeuticsBoard Membercurrent2025 — present
- Temmune TherapeuticsBoard Membercurrent2025 — present
- ExelixisBoard Membercurrent2023 — present
- Legend BiotechBoard Membercurrent2022 — present
- Akero TherapeuticsBoard Membercurrent2020 — present
- IMEC VZWBoard Membercurrent2012 — present
- Johnson & JohnsonPresident JJDC2015 — 2019
- Johnson & JohnsonHead Business Development Johnson&johnson Pharmaceutical Group1992 — 2015New Brunswick, New Jersey, United States
Colleagues at Bioqube Ventures
Alexander Demoulin
Associate at Bioqube Ventures
Clement Salque
Associate at Bioqube Ventures
Debora Dumont
Managing Partner at Bioqube Ventures
Dirk Reyn
Managing Partner at Bioqube Ventures
Geert Tackaert
Finance Director at Bioqube Ventures
Jacques Mizrahi
Venture Partner at Bioqube Ventures
Janine Schuurman
Senior Advisor at Bioqube Ventures
Jon Edwards
Managing Partner at Bioqube Ventures
Frequently asked questions
- Where does Tom Heyman work?
- Tom Heyman is Executive Partner at Bioqube Ventures.
Shared employers
Also worked at Bioqube Ventures15
Debora DumontManaging Partner at Bioqube VenturesDirk ReynManaging Partner at Bioqube VenturesNico VandervelpenManaging Partner at Bioqube VenturesJoris De MaeyerExecutive in Residence at Bioqube VenturesJoris VanderlochtChief Scientific Director at Bioqube VenturesAlexander DemoulinAssociate at Bioqube Ventures
+ 9 more
